Next Financial Group’s BioLineRX BLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$6K Hold
68
﹤0.01% 2353
2021
Q3
$8K Sell
68
-22
-24% -$2.61K ﹤0.01% 2083
2021
Q2
$10K Hold
90
﹤0.01% 1973
2021
Q1
$10K Hold
90
﹤0.01% 1878
2020
Q4
$9K Hold
90
﹤0.01% 1801
2020
Q3
$6K Buy
+90
New +$6.8K ﹤0.01% 1768
2020
Q2
Sell
-90
Closed -$5K 752
2020
Q1
$5K Sell
90
-20
-18% -$1.58K ﹤0.01% 1692
2019
Q4
$10K Sell
110
-78
-41% -$8.03K ﹤0.01% 1761
2019
Q3
$20K Buy
188
+66
+54% +$9.15K ﹤0.01% 1438
2019
Q2
$27K Buy
122
+55
+82% +$12.3K ﹤0.01% 1356
2019
Q1
$17K Hold
67
﹤0.01% 995
2018
Q4
$17K Sell
67
-50
-43% -$24.1K ﹤0.01% 1150
2018
Q3
$75K Hold
117
0.03% 438
2018
Q2
$62K Hold
117
0.02% 286
2018
Q1
$61K Buy
117
+4
+4% +$2.45K 0.01% 409
2017
Q4
$74K Hold
113
0.03% 273
2017
Q3
$78K Buy
113
+44
+64% +$27.3K 0.02% 568
2017
Q2
$35K Hold
69
0.01% 879
2017
Q1
$36K Sell
69
-14
-17% -$9.01K 0.01% 822
2016
Q4
$46K Hold
83
0.01% 1003
2016
Q3
$57K Buy
83
+17
+26% +$9.06K 0.01% 888
2016
Q2
$31K Hold
66
0.01% 788
2016
Q1
$40K Buy
66
+3
+5% +$1.89K 0.01% 688
2015
Q4
$48K Hold
63
0.02% 627
2015
Q3
$57K Hold
63
0.02% 593
2015
Q2
$99K Hold
63
0.03% 470
2015
Q1
$79K Buy
63
+15
+31% +$18.5K 0.03% 529
2014
Q4
$46K Buy
48
+15
+45% +$13K 0.02% 679
2014
Q3
$30K Buy
33
+4
+14% +$4.29K 0.01% 1200
2014
Q2
$30K Buy
+29
New +$36.3K 0.02% 476

Other funds holding BLRX

Next Financial Group's BLRX Position: Q4 2021 in Review

Next Financial Group held its BioLineRX (BLRX) position steady in Q4 2021 at 68 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #2353.

Next Financial Group first reported a position in BLRX in Q2 2014 and has held it in 30 quarters since. The position peaked at $99K in Q2 2015. 30 funds tracked by Wall St. Rank hold BLRX as of Q4 2021.

  • Next Financial Group held 68 shares of BioLineRX worth $6K as of Q4 2021.
  • Next Financial Group left its BioLineRX share count unchanged in Q4 2021.
  • BioLineRX made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2353 holding.
  • Next Financial Group first reported a position in BioLineRX in Q2 2014 and has held it in 30 quarters since.
  • Next Financial Group's BioLineRX position peaked at $99K in Q2 2015.
  • 30 funds tracked by Wall St. Rank held BioLineRX as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.